The Defense Logistics Agency plans a national requirements contract for Febuxostat Tablets (40 MG and 80 MG, 30-count bottles), with a one-year base and four one-year options. This is an unrestricted, fully competitive, firm-fixed price acquisition for commercial items. The contract will serve Department of Defense, Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through DLA and VA prime vendor programs. The projected solicitation date is June 2026, though DLA may issue it earlier or later. No budget amount or performance location is specified.